| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/10/2001 | EP1141311A1 Protective antigen of group a streptococci (spa) |
| 10/10/2001 | EP1141309A1 Streptococcal abc transporter protein |
| 10/10/2001 | EP1141308A2 Group b streptococcus proteins, and their use |
| 10/10/2001 | EP1141299A2 Il-1 related polypeptides |
| 10/10/2001 | EP1141298A2 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 10/10/2001 | EP1141297A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141292A1 Monocyte-derived nucleic acids and related compositions and methods |
| 10/10/2001 | EP1141289A2 Compositions and method for the treatement of tumors |
| 10/10/2001 | EP1141288A2 Lymphocytic membrane proteins |
| 10/10/2001 | EP1141287A1 Pancreatic polypeptide zsig66 |
| 10/10/2001 | EP1141286A1 Cytokine receptor chain |
| 10/10/2001 | EP1141285A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/10/2001 | EP1141284A2 Methods and compositions for inhibiting neoplastic cell growth |
| 10/10/2001 | EP1141280A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 10/10/2001 | EP1141279A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 10/10/2001 | EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy |
| 10/10/2001 | EP1141271A1 Selection of monoclonal antibodies |
| 10/10/2001 | EP1141270A1 Ethylene-response-factor1 (erf1) in plants |
| 10/10/2001 | EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF |
| 10/10/2001 | EP1141248A2 A METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-$g(b) RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 10/10/2001 | EP1141247A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141240A1 Use of cd40 engagement to alter t cell receptor usage |
| 10/10/2001 | EP1141237A1 Pth receptor and screening assay utilizing the same |
| 10/10/2001 | EP1141028A2 Human monoclonal antibodies to ctla-4 |
| 10/10/2001 | EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 10/10/2001 | EP1141026A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 10/10/2001 | EP1141024A2 Polypeptide variants with altered effector function |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/10/2001 | EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 10/10/2001 | EP1141017A2 Characterization of the soc/crac calcium channel protein family |
| 10/10/2001 | EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 10/10/2001 | EP1141009A2 Reagents and methods useful for detecting diseases of the breast |
| 10/10/2001 | EP1141001A2 Screening methods based on the use of protein kinases |
| 10/10/2001 | EP1141000A1 Superantigens |
| 10/10/2001 | EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140997A2 Chlamydia trachomatis antigens |
| 10/10/2001 | EP1140996A2 Type iii secretion system antigens from bordetella pertussis |
| 10/10/2001 | EP1140995A2 Peptides for inhibiting hbv core proteins |
| 10/10/2001 | EP1140994A1 Outer surface proteins, their genes, and their use |
| 10/10/2001 | EP1140987A1 Peptides for inhibiting hpv e6 proteins |
| 10/10/2001 | EP1140978A1 Methods of identifying antigen gene sequences |
| 10/10/2001 | EP1140973A1 Protein-protein interactions in neurodegenerative disorders |
| 10/10/2001 | EP1140970A1 47 human secreted proteins |
| 10/10/2001 | EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140968A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 10/10/2001 | EP1140967A1 Targeted gene transfer using g protein coupled receptors |
| 10/10/2001 | EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140206A1 Interferon gamma inducing factor based vaccine and use of same for protective immunity against multiple sclerosis |
| 10/10/2001 | EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 10/10/2001 | EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 10/10/2001 | EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia |
| 10/10/2001 | EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 10/10/2001 | EP1140175A2 Antibodies to truncated vegf-d and uses thereof |
| 10/10/2001 | EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 10/10/2001 | EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 10/10/2001 | EP1140172A1 The prevention and treatment for retinal ischemia and edema |
| 10/10/2001 | EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 10/10/2001 | EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 10/10/2001 | EP1140169A2 Methods and compositions for decreasing allergic reactions to surface allergens |
| 10/10/2001 | EP1140168A1 Use of antibodies for anticancer vaccination |
| 10/10/2001 | EP1140157A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 10/10/2001 | EP1140153A2 Improvement of tolerance to a xenograft |
| 10/10/2001 | EP1140146A1 Porcine b7-1 and antibodies thereto |
| 10/10/2001 | EP1140120A2 Human brainiac-5 |
| 10/10/2001 | EP1032597A4 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 10/10/2001 | EP0840620B1 Il-8 antagonists for treatment of asthma |
| 10/10/2001 | EP0667898B1 Uses of the tau/neurofilament protein kinase pk40 |
| 10/10/2001 | CN1317088A Diagnostic method for detecting disturbances of pancreas |
| 10/10/2001 | CN1317047A GBS toxin receptor |
| 10/10/2001 | CN1317046A Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
| 10/10/2001 | CN1317044A Nucleic acids encoding proteins involved in sensory transduction |
| 10/10/2001 | CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui |
| 10/10/2001 | CN1317015A Human anti-factor IX/IXa antibodies |
| 10/10/2001 | CN1317014A Antibody for detecting microorganism |
| 10/10/2001 | CN1317010A Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 10/10/2001 | CN1316910A Composition and methods for regulating lymphocyte activation |
| 10/10/2001 | CN1316515A Human liver cancer related cancer suppressing protein and its coding sequence |
| 10/10/2001 | CN1316438A Process for preparing and testing recombinant glucokinese antibody as novel thrombolytics |
| 10/10/2001 | CN1316437A Humanized neutralizing generatically engineering Fab antibody of hepatitis A virus |
| 10/10/2001 | CN1316435A Human testicular development specificity protein-8 gene coding protein |
| 10/10/2001 | CN1316434A Human specific protein kinase-15 gene coding protein |
| 10/10/2001 | CN1316433A Human exonuclease factor gene coding protein |
| 10/10/2001 | CN1072506C Improved diplococuus meninigitidis polysaccharide conjugate vaccine |
| 10/09/2001 | US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease |
| 10/09/2001 | US6300484 DNA encoding DP. 75 and a process for its use |
| 10/09/2001 | US6300479 Immunoglobulins; for use in diagnosis and treatment of cancer |
| 10/09/2001 | US6300476 Anti-peptide antibody against human cytochrome P450 3A4 |
| 10/09/2001 | US6300472 Rab proteins |
| 10/09/2001 | US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides |
| 10/09/2001 | US6300310 Amino acid sequence with segments of polypeptides |
| 10/09/2001 | US6300308 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 10/09/2001 | US6300131 Telomerase-associated proteins |